Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter CD3 epsilon Antikörper

Dieser Anti-CD3 epsilon Antikörper ist ein Human Monoklonal Antikörper zur Detektion von CD3 epsilon in FACS. Geeignet für Human.
Produktnummer ABIN7795312

Kurzübersicht für Rekombinanter CD3 epsilon Antikörper (ABIN7795312)

Target

Alle CD3 epsilon (CD3E) Antikörper anzeigen
CD3 epsilon (CD3E)

Antikörpertyp

Recombinant Antibody

Reaktivität

  • 351
  • 207
  • 51
  • 43
  • 21
  • 19
  • 8
  • 8
  • 8
  • 7
  • 5
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 210
  • 175
  • 47
  • 38
  • 23
  • 12
  • 6
  • 2
  • 2
  • 1
  • 1
Human

Klonalität

  • 394
  • 115
  • 7
Monoklonal

Konjugat

  • 180
  • 39
  • 35
  • 24
  • 23
  • 12
  • 11
  • 11
  • 11
  • 11
  • 11
  • 11
  • 8
  • 8
  • 8
  • 8
  • 6
  • 6
  • 6
  • 6
  • 6
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser CD3 epsilon Antikörper ist unkonjugiert

Applikation

  • 367
  • 217
  • 182
  • 133
  • 118
  • 88
  • 48
  • 33
  • 32
  • 27
  • 27
  • 22
  • 21
  • 14
  • 13
  • 8
  • 6
  • 5
  • 5
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS)

Klon

OKT3
  • Expressionssystem

    Mammalian cells

    Verwendungszweck

    Recombinant Anti-human CD3e Monoclonal Antibody (Clone: OKT3), Human IgG1 Fc Silent Kappa

    Produktmerkmale

    The OKT3 antibody binds to CD3 epsilon of the T cell receptor-CD3 complex found only on mature T cells and medullary thymocytes. An interaction between T cells, OKT3, and monocytes causes T-cell activation (mitogenesis) in vitro. On the other hand, the OKT3 antibody blocks the unique association between the antigen receptor and CD3, and both the generation and function of cytotoxic T cells. After an initial dose of the OKT3 antibody, T cells disappear from the circulation within minutes to hours. During treatment with the OKT3 antibody, T cells bearing the usual array of surface molecules (CD2, CD4, and CD8) reappear in the peripheral blood circulation but these cells are devoid of CD3. After another 48 hours without the OKT3 antibody, the normal array of surface molecules including CD3 appear again on all T cells. The selective removal of CD3 by internalization is thought to be the key mechanism of action of the OKT3 antibody. Comodulation of the antigen receptor with CD3 explains the immunoblocking action of the OKT3 antibody in vivo. The OKT3 antibody is ineffective clinically if the CD3 target molecule is not modulated. The OKT3 antibody is effective for induction of immunosuppression and for treating initial and steroid-resistant rejections.

    Aufreinigung

    Protein A or G affinity column

    Reinheit

    >95 % by reducing SDS-PAGE

    Isotyp

    Fc Silenced, IgG1
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    > 3 mg/mL

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.
  • Target

    CD3 epsilon (CD3E)

    Andere Bezeichnung

    CD3e

    Pathways

    T-Zell Rezeptor Signalweg, CXCR4-mediated Signaling Events, Ubiquitin Proteasome Pathway
Sie sind hier:
Chat with us!